Efficacy and safety of rituximab for autoimmune neutropenia: a French case series and literature review

Rheumatology (Oxford). 2020 Sep 1;59(9):2637-2640. doi: 10.1093/rheumatology/keaa045.
No abstract available

Publication types

  • Letter

MeSH terms

  • Autoimmune Diseases* / blood
  • Autoimmune Diseases* / drug therapy
  • Female
  • France
  • Humans
  • Immunologic Factors / administration & dosage
  • Immunologic Factors / adverse effects
  • Leukocyte Count / methods
  • Male
  • Middle Aged
  • Neutropenia* / drug therapy
  • Neutropenia* / etiology
  • Neutropenia* / immunology
  • Recurrence
  • Retreatment / statistics & numerical data
  • Retrospective Studies
  • Rituximab* / administration & dosage
  • Rituximab* / adverse effects
  • Treatment Outcome

Substances

  • Immunologic Factors
  • Rituximab